PSI CRO is a full-service global Contract Research Organization (CRO) based in Zug, Switzerland, founded in 1995. The company specializes in managing Phase 2 and Phase 3 clinical trials, focusing on predictable patient enrollment and timely delivery. With a workforce of around 3,000 employees across more than 50 countries, PSI CRO has grown organically and emphasizes quality assessments and high customer satisfaction, achieving a 95% repeat/referral business rate. PSI CRO offers comprehensive clinical trial management services, including patient enrollment, site management, and regulatory support. The company has expertise in complex trial designs, particularly in oncology, hematology, gastroenterology, and precision medicine. Its proprietary tool, VISIONAL™, enhances feasibility and enrollment predictions, contributing to a high success rate in study timelines. PSI CRO partners with pharmaceutical and biotechnology companies, playing a significant role in pivotal registration trials and delivering a notable percentage of FDA-approved oncology drugs.